Wellinks secures $10m for respiratory disease RPM tool’s advancement
The first close of the company’s Series B financing round was led by the UMass Memorial Health (UMMH) and internal...
The first close of the company’s Series B financing round was led by the UMass Memorial Health (UMMH) and internal...
Bank of America awarded funding to UMass Memorial Health to expand the North Pavilion at UMass Memorial Medical Center...
UMass Memorial Medical Center was named among The Best Regional Hospitals for Community Access that demonstrate...
At UMass Memorial Medical Center, the clinical partner of UMass Chan Medical School, pharmacy residents train in a large academic medical center where they care for diverse patient populations, collaborate with nationally recognized interdisciplinary teams and gain experience across a broad range of clinical, operational and specialty pharmacy settings. With more than 300 pharmacy professionals supporting care across five campuses, residents are immersed in one of the most comprehensive pharmacy practice environments in Central Massachusetts and beyond.
There’s now an alternative treatment — and new hope — for people with difficult-to-treat depression. UMass Memorial Health offers esketamine nasal spray, a breakthrough treatment for adults (18 and up). Unlike antidepressants, which take weeks to work, esketamine can help you feel better within 24 hours. You receive safe, attentive care from our experienced psychiatrists and nurses.
Esketamine is an FDA-approved nasal spray derived from the drug ketamine, an anesthetic for pain. It works by quickly...
The Worcester Board of Health voted Monday night to approve a series of updates to the city’s tobacco regulations...